Elanco Animal Health (ELAN) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Elanco Animal Health may face heightened business risk due to shareholder activism, a trend on the rise among public companies. Activist shareholders, engaging in tactics like proxy battles or hostile takeovers, could distract Elanco’s management and Board from their strategic goals. This could lead to instability in the company’s future direction, strain relationships with partners, and pose challenges in attracting and maintaining a skilled workforce. Moreover, the financial burden of legal defenses against such activism may incur significant expenses, potentially harming Elanco’s stock value and investor confidence.
The average ELAN stock price target is $17.07, implying 4.98% upside potential.
To learn more about Elanco Animal Health’s risk factors, click here.
